Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values

Eur Radiol. 2012 Aug;22(8):1820-8. doi: 10.1007/s00330-012-2432-3. Epub 2012 Apr 17.

Abstract

Objectives: To evaluate the influence of the choice of b values on the diagnostic value of the apparent diffusion coefficient (ADC) for detection and grading of prostate cancer (PCa).

Methods: Forty-one patients with biopsy-proven PCa underwent endorectal 3-T MRI before prostatectomy. Different combinations of b values (0-800 s/mm(2)) were used to calculate four representative ADC maps. Mean ADCs of tumours and non-malignant tissue were determined. Tumour appearance on different ADC maps was rated by three radiologists as good, fair or poor by assigning a visual score (VS) of 2, 1 or 0, respectively. Differences in the ADC values with the choice of b values were analysed using one-way ANOVA.

Results: Choice of b values had a highly (P < 0.001) significant influence on the absolute ADC in each tissue. Maps using b = [50, 800] and [0, 800] were rated best (VS= 1.6 ± 0.3) and second best (1.1 ± 0.3, P < 0.001), respectively. For low-grade carcinomas (Gleason score ≤ 6, 13/41 patients), only the former choice received scores better than fair (VS = 1.4 ± 0.3). Mean tumour ADCs showed significant negative correlation (Spearman's ρ -0.38 to -0.46, P < 0.05) with Gleason score.

Conclusions: Absolute ADC values strongly depend on the choice of b values and therefore should be used with caution for diagnostic purposes. A minimum b value greater than zero is recommended for ADC calculation to improve the visual assessment of PCa in ADC maps.

Key points: • Absolute ADC values are highly dependent on the choice of b values. • Absolute ADC thresholds should be used carefully to predict tumour aggressiveness. • Subjective ratings of ADC maps involving b = 0 s/mm ( 2 ) are poor to fair. • Minimum b value greater than 0 s/mm ( 2 ) is recommended for ADC calculation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Diagnostic Imaging / methods
  • Diagnostic Imaging / standards
  • Diffusion
  • Echo-Planar Imaging / methods
  • Humans
  • Image Processing, Computer-Assisted
  • Magnetic Resonance Imaging / methods*
  • Magnetic Resonance Imaging / standards
  • Male
  • Medical Oncology / methods*
  • Middle Aged
  • Neoplasm Grading
  • Observer Variation
  • Prostate-Specific Antigen / biosynthesis
  • Prostatectomy / methods
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / pathology*
  • Retrospective Studies

Substances

  • Prostate-Specific Antigen